| Authors: |
Branagan AR; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Mo C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lei M; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Gustine JN; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Yee AJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., O'Donnell E; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Castillo JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Nadeem O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Flynn C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Bernstein Z; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Nakamoto-Matsubara R; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Meid K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Verma R; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Hunter ZR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Guerrera ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Alter G; Division of Medical Sciences, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA., Burke J; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Harrington C; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Agyemang E; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Gammon M; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Lively K; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Packer L; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Horick N; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Laubach J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Munshi N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Treon SP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Raje NS; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Sarosiek SR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. |
